VBIO ▲ +8.4% - Valion Bio, Inc.
$VBIO - Valion Appoints Life Sciences Veteran Dean Zikria as Interim CEO and Announces Board Leadership Transitions
Valion Bio rose 8.4% following the appointment of life sciences veteran Dean Zikria as interim CEO and related board leadership changes. The executive transition appeared to signal investor confidence in the company's strategic direction under new leadership.
23-SEP-2026 08:00 AM ET
Share this post
More filings for $VBIO
VBIO ▼ -1.7% - Valion Bio, Inc.Sep 22, 2026VBIO ▼ -5.6% - Valion Bio, Inc.Sep 1, 2026VBIO - Valion Bio, Inc. - SEC Filing Update (27-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 28, 2026VBIO ▼ -18.8% - Valion Bio, Inc.Aug 27, 2026VBIO - Valion Bio, Inc. - SEC Filing Update (24-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 25, 2026VBIO - Valion Bio, Inc. - SEC Filing Update (19-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 20, 2026
View full $VBIO filing history →💬 Comments
Loading comments…
Leave a comment